Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, February 12 2016 7:31pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Friday, Feb 12, 2016
·Munger on IBM, Life Advice, Why Valeant Comments Brought 'Nothing But Trouble'
- Fri 3:50 pm ET
·Valeant uses rare accounting maneuver for acquisitions that cushions income
at MarketWatch - Fri 7:03 am ET
Thursday, Feb 11, 2016
·One Reason Why Valeant (VRX) Stock Is Retreating Today
at - Thu 3:23 pm ET
·Why You Are a Better Investor Than Bill Ackman
at Fortune - Thu 3:01 pm ET
·Delcath announces Engagement of Lars E. Birgerson, M.D., Ph. D as global medical consultant
PR Newswire - Thu 8:30 am ET
·Flamel Technologies to Present at RBC Capital Markets' 2016 Global Healthcare Conference
Marketwire - Thu 8:00 am ET
Wednesday, Feb 10, 2016
·Bill Ackman’s Pershing Square slides 8.2% in February
at MarketWatch - Wed Feb 10
·Bill Ackman's Pershing Square falls 8.2% in February
at MarketWatch - Wed Feb 10
·SEC Investigating Ex-Salix Executives Over Misleading Investors
- Wed Feb 10
·Who Will Come Out On Top As Flu Season Draws Down
- Wed Feb 10
·Delcath Announces Beginning Of Patient Enrollment In Phase 3 Focus Trial
PR Newswire - Wed Feb 10
·Alkermes Announces Initiation of Second Phase 3 Study of ALKS 3831 for Schizophrenia
Business Wire - Wed Feb 10
Tuesday, Feb 9, 2016
·SEC investigating former Salix Pharma execs, Reuters reports
at - Tue Feb 9
·Here’s What Wall Street Thinks of Bill Ackman’s New Herbalife Attack
at Fortune - Tue Feb 9
·3 Reasons Valeant Pharmaceuticals Intl. Inc. Was Clobbered in January
at Motley Fool - Tue Feb 9
·The Best Stock To Take Advantage Of This Booming Industry
- Tue Feb 9
·Pharming and Cytobioteck Announce Extension of Distribution Agreement for RUCONEST®
PR Newswire - Tue Feb 9
Monday, Feb 8, 2016
·Flamel Technologies Acquires FSC Pediatrics
Marketwire - Mon Feb 8
Sunday, Feb 7, 2016
·Lou Simpson Adds to Valeant Stake
- Sun Feb 7
Thursday, Feb 4, 2016
·NovaDel Reports Resolution of Contingent Liabilities
Business Wire - Thu Feb 4
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?